PEOPLE - Changes at Arthro Kinetics:
This article was originally published in Clinica
Executive Summary
Arthro Kinetics (Esslingen, Stuttgart), a developer of biological implants for joint regeneration and surgical systems for minimally-invasive spinal surgery, has promoted Jason Loveridge to CEO. Previously a non-executive director, Dr Loveridge's 18 years in the biotech industry include periods at BioPharma Capital (specialist asset manager for life science companies), of which he was a co-founder; venture capitalist: Korda & Co (specialist early-stage investor); and senior member at JAFCO Nomura (a global life sciences investment committee).
You may also be interested in...
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.